Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Quinolone. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN1054980A details chiral synthesis of 3-amino-4-methylpyrrolidine derivatives from natural amino acids, enabling high-purity quinolone antibiotic production with improved supply chain stability.
Patent CN1151151C details a novel route for 8-methoxy-quinolone carboxylic acids. Achieve cost reduction in API manufacturing with high-purity antibiotics.
Patent CN118580187A reveals green chlorophyll photocatalysis for dihydroisoquinolone synthesis. Offers cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN113651707A reveals a high-yield, 3-step synthesis for ortho-amino trifluoroacetophenone. Discover cost-effective manufacturing and scalable supply chain solutions.
Patent CN102766098B details a novel synthesis route for 4-oxo quinolone compounds offering improved purity and scalable manufacturing for pharmaceutical supply chains.
Novel synthesis route offers high yield and safety for finafloxacin intermediate production. Reduces toxic waste and ensures supply chain stability for global pharmaceutical manufacturers seeking reliable partners.
Novel catalytic route for high-purity fluoroquinolone intermediates. Reduces alkali usage and boosts yield to 82.5% via one-pot synthesis.
Patent CN1046523C details a high-yield phosgene-mediated coupling process for quinolone lactam antibacterial agents, offering significant cost reduction in API manufacturing.
Patent CN102153512B reveals a mixed-acid hydrolysis method for Rebamipide intermediates, offering superior yield and purity for global supply chains.
Patent CN104262249A reveals solvent-free hydroamination for quinolones. Reduces waste and improves supply chain reliability for pharmaceutical manufacturers.
Patent CN1031795C reveals a novel boron complex route for 8-alkoxyquinolones, eliminating corrosive HF byproducts and enabling cost-effective pharmaceutical manufacturing.
Patent CN104520275A details a novel synthetic route for HIV integrase inhibitors offering improved safety and supply chain reliability for pharmaceutical manufacturing.
Patent CN108558753A details a mild quinolone synthesis method using iron pentacarbonyl. This approach offers significant supply chain safety and cost reduction advantages for pharmaceutical intermediates manufacturing.
Patent CN101302195B reveals a solid-acid catalyzed synthesis for 7-Hydroxy-3,4-dihydroquinolone, offering high purity and reduced environmental impact for Aripiprazole manufacturing.
Patent CN108084161A details a novel Delafloxacin synthesis route offering high purity and yield. This report analyzes cost reduction in API manufacturing and supply chain reliability for global buyers.
Patent CN110204489B reveals a safe, one-pot quinolone synthesis using solid chromium hexacarbonyl. Discover cost-effective manufacturing and scalable supply solutions.
Patent CN101838238A reveals a green cyclization method reducing waste and boosting yield for scalable quinolone antibiotic production.
Novel 6-step synthesis for quinolone intermediate CN105801482B. High purity over 99 percent, reduced pollution, scalable process for reliable pharmaceutical intermediates supplier.
Patent CN112239456B details a safe palladium-catalyzed carbonylation route for 2,3-dihydroquinolones, offering significant cost reduction in API manufacturing and scalable production.
Novel palladium-catalyzed carbonylation method for high-purity quinolone intermediates. Reduces costs and enhances supply chain reliability for pharmaceutical manufacturing.